awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38060734-904934AA-C4FF-4FC6-A40F-71CE19D7C9DF
Q38060734-904934AA-C4FF-4FC6-A40F-71CE19D7C9DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38060734-904934AA-C4FF-4FC6-A40F-71CE19D7C9DF
Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy.
P2860
Q38060734-904934AA-C4FF-4FC6-A40F-71CE19D7C9DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38060734-904934AA-C4FF-4FC6-A40F-71CE19D7C9DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4f084f38f9bb3327905112f80f3351eb9500637f
P2860
The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression.